Evidence map›Paper›PMID 21145500›Full record

ArticleDevelopmental cell2010

mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion.

Lunhua Liu, Satarupa Das, Wolfgang Losert, Carole A Parent

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 218 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. mTOR signaling governs the formation of epithelial apical projections via S6K1-RhoA and aPKC-Lgl2 axes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Frontiers in immunology · 2026
    Review
  7. Review
  8. Article
  9. CD24 Regulates the Formation of Ectosomes in B Lymphocytes.Journal of extracellular vesicles · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. ELMO1 Deficiency Reduces Neutrophil Chemotaxis in Murine Peritonitis.International journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lunhua LiuCenter for Cancer Research, NCI, NIH, Bethesda, MD 20892, USA.
Satarupa Das
Wolfgang Losert
Carole A Parent
Center for Cancer Research · USUniversity of Maryland, College Park · US

Funding

CHEMOTACTIC SIGNALS REGULATING HUMAN NEUTROPHIL AND BREAST METASTATIC MIGRATIONZIABC011216 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PARENT, CAROLE · 2009 to 2017
$8.6M
Intramural NIH HHS ZIA BC011216
6 · The paper itself

Abstract

We studied the role of the target of rapamycin complex 2 (mTORC2) during neutrophil chemotaxis, a process that is mediated through the polarization of actin and myosin filament networks. We show that inhibition of mTORC2 activity, achieved via knock down (KD) of Rictor, severely inhibits neutrophil polarization and directed migration induced by chemoattractants, independently of Akt. Rictor KD also abolishes the ability of chemoattractants to induce cAMP production, a process mediated through the activation of the adenylyl cyclase 9 (AC9). Cells with either reduced or higher AC9 levels also exhibit specific and severe tail retraction defects that are mediated through RhoA. We further show that cAMP is excluded from extending pseudopods and remains restricted to the cell body of migrating neutrophils. We propose that the mTORC2-dependent regulation of MyoII occurs through a cAMP/RhoA-signaling axis, independently of actin reorganization during neutrophil chemotaxis.

Indexed as

ActinsAdenylyl Cyclase InhibitorsAdenylyl CyclasesBase SequenceCarrier ProteinsCell LineCell PolarityChemotaxis, LeukocyteCyclic AMPEnzyme ActivationGene Knockdown TechniquesHumansModels, BiologicalMyosin Type IINeutrophilsN-Formylmethionine Leucyl-PhenylalanineActinsadenylate cyclase 9Adenylyl Cyclase InhibitorsAdenylyl CyclasesCarrier ProteinsCyclic AMPMyosin Type IIN-Formylmethionine Leucyl-PhenylalanineProtein Kinase CProto-Oncogene Proteins c-aktRapamycin-Insensitive Companion of mTOR ProteinrhoA GTP-Binding ProteinRHOA protein, humanRICTOR protein, humanRNA, MessengerRNA, Small InterferingTOR Serine-Threonine Kinases

Identifiers

PMID21145500
PMCPMC3071587
OpenAlexW2042020095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.